Key result
Elevated miR-3615 expression was associated with acute coronary syndrome, major adverse cardiovascular events, and increased coronary lesion severity.
Why the study?
Does serum miR-3615 expression serve as a diagnostic and prognostic biomarker in patients with acute coronary syndrome?
Case-Control (n=193)
Does serum miR-3615 expression serve as a diagnostic and prognostic biomarker in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Upregulation of serum miR-3615 serves as a potential diagnostic and prognostic biomarker for acute coronary syndrome and promotes pathological changes in coronary smooth muscle cells.
Background Acute coronary syndrome (ACS), a cardiovascular disease with high mortality, is closely associated with microRNA (miRNA) dysregulation, making miRNAs promising targets for diagnostic and therapeutic development. Aim This study evaluated the clinical value of miR-3615 in ACS and its pathological mechanism. Methods This study included 121 ACS patients and 72 controls; miR-3615 and DPF3 expression were quantified by qRT-PCR. The clinical diagnostic and prognostic value of miR-3615 was analyzed through the ROC curve, correlation analysis, multivariate regression analysis, and K-M survival analysis. In vitro, a cell model of human coronary artery smooth muscle cells (HCASMCs) was established by inducing oxidized low-density lipoprotein (ox-LDL). Inflammatory markers were analyzed using ELISA kits. CCK-8 and Transwell assays were used to evaluate cell proliferation and migration abilities. The targeting effect of miR-3615 on DPF3 was confirmed by dual luciferase assay. Results MiR-3615 expression was elevated in ACS patients, especially among those who experienced major adverse cardiovascular events (MACE). Furthermore, its levels showed a positive correlation with both the Gensini score (indicating coronary lesion severity) and cardiac troponin I (cTnI, a marker of myocardial injury). MiR-3615 has a high degree of accuracy in diagnosing ACS and predicting poor prognosis. In an ox-LDL-induced HCASMCs model, inhibition of miR-3615 effectively attenuated pathological cell proliferation, migration, and inflammatory responses. DPF3 was identified as a target of miR-3615. Conclusions MiR-3615 is expected to become a potential biomarker for the diagnosis and prognosis of ACS. Moreover, the upregulation of miR-3615 may induce damage to HCASMCs, thereby participating in the occurrence and development of ACS.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a case-control in Acute coronary syndrome (n=193). Elevated miR-3615 expression vs. Controls was evaluated on Diagnosis of ACS and occurrence of major adverse cardiovascular events (MACE). Elevated miR-3615 expression was associated with acute coronary syndrome, major adverse cardiovascular events, and increased coronary lesion severity.
Synapse has enriched 10 related papers. Consider them for comparative context: